This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsCandel TherapeuticsCandel Therapeutics Funding Rounds, Valuation & Investors
Candel Therapeutics company logo
Develops biological immunotherapies to fight cancer51-200 Employees
View 0 jobs

Candel Therapeutics Funding

$50M
11 round
Candel Therapeutics is active in the following markets / industries: B2B and professional services. The company has secured funding across 1 rounds, totaling in an amount of $50M. Their most recent funding was raised on October 14, 2025.

Funding Rounds

S
$50000000